Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.47 million shares were traded. MREO stock price reached its highest trading level at $1.8299 during the session, while it also had its lowest trading level at $1.75.
Ratios:
For a deeper understanding of Mereo Biopharma Group Plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.71 and its Current Ratio is at 8.71. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, JP Morgan on March 27, 2025, initiated with a Overweight rating and assigned the stock a target price of $7.
On December 06, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $7. On June 13, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $8.Robert W. Baird initiated its Outperform rating on June 13, 2024, with a $8 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MREO now has a Market Capitalization of 284845728 and an Enterprise Value of 1375927680. For the stock, the TTM Price-to-Sale (P/S) ratio is 558.41 while its Price-to-Book (P/B) ratio in mrq is 6.11. Its current Enterprise Value per Revenue stands at 2751.855 whereas that against EBITDA is -30.556.
Stock Price History:
The Beta on a monthly basis for MREO is 0.40, which has changed by -0.497191 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, MREO has reached a high of $3.94, while it has fallen to a 52-week low of $1.47. The 50-Day Moving Average of the stock is -6.23%, while the 200-Day Moving Average is calculated to be -17.14%.
Shares Statistics:
For the past three months, MREO has traded an average of 1.31M shares per day and 1349080 over the past ten days. A total of 159.10M shares are outstanding, with a floating share count of 137.50M. Insiders hold about 13.57% of the company’s shares, while institutions hold 56.40% stake in the company. Shares short for MREO as of 1763078400 were 9249501 with a Short Ratio of 7.72, compared to 1760486400 on 11162287. Therefore, it implies a Short% of Shares Outstanding of 9249501 and a Short% of Float of 8.17.
Earnings Estimates
The performance of Mereo Biopharma Group Plc ADR (MREO) in the stock market is under the watchful eye of 6.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $0.0, with high estimates of $0.04 and low estimates of -$0.01.
Analysts are recommending an EPS of between -$0.01 and -$0.05 for the fiscal current year, implying an average EPS of -$0.04. EPS for the following year is -$0.01, with 5.0 analysts recommending between $0.1 and -$0.05.
